AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

 8,550.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 9,320.00p
  • 52 Week Low: 6,221.00p
  • Currency: UK Pounds
  • Shares Issued: 1,312.28m
  • Volume: 0
  • Market Cap: 112,200m
  • RiskGrade: 160

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 2.5% 2.5%
Div Cover 0.4 1.4
Op Mrgn 12.0% 24.8%
ROCE 76.9%  
Latest F'cast
P/E 108.5 27.3
PEG n/a 0.1
Pr/Revenue 6.0 5.4
Pr/Book 10.0  
Latest F'cast
Revenue 10.4% -36.2%
PBT -22.3% 149.1%
EPS -39.4% 288.5%
DPS n/a -41.7%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 24,708.00 3,069.00 426.00¢ 14.2 n/a -0% 280.00¢ 4.6%
31-Dec-16 23,002.00 3,552.00 431.00¢ 13.5 13.5 +1% 280.00¢ 4.8%
31-Dec-17 22,465.00 2,227.00 428.00¢ 15.7 n/a -1% 280.00¢ 4.2%
31-Dec-18 22,090.00 1,993.00 170.00¢ 45.2 n/a -60% 280.00¢ 3.6%
31-Dec-19 24,384.00 1,548.00 103.00¢ 96.7 n/a -39% 280.00¢ 2.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 20,368.26 5,047.61 306.33p 27.9 0.1 +288% 213.73p 2.5%
31-Dec-21 22,800.78 6,306.53 383.91p 22.3 0.9 +25% 216.22p 2.5%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

AstraZeneca prices a $3bn bond issue 04-Aug-2020 07:00 RNS
Total Voting Rights 03-Aug-2020 15:00 RNS
Tagrisso US BTD for EGFRm adjuvant lung cancer 30-Jul-2020 07:25 RNS

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 8,550.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 9,320.00p
52 Week Low 6,221.00p
Volume 0
Shares Issued 1,312.28m
Market Cap 112,200m
RiskGrade 160

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.43% below the market average39.43% below the market average39.43% below the market average39.43% below the market average39.43% below the market average
82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average
Price Trend
82.65% above the market average82.65% above the market average82.65% above the market average82.65% above the market average82.65% above the market average
36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average
Income
77.44% below the market average77.44% below the market average77.44% below the market average77.44% below the market average77.44% below the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Growth
89.28% below the market average89.28% below the market average89.28% below the market average89.28% below the market average89.28% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 17
Buy 0
Neutral 3
Sell 2
Strong Sell 3
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 13-Aug-20 27-Feb-20
Paid 14-Sep-20 30-Mar-20
Amount 90.00¢ 190.00¢

Trades for --2020

Time Volume / Share Price
0 @ 0.000p

Top of Page